• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MMJ
Click for more information
4.76% 11.0¢

MMJ GROUP HOLDINGS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MMJ MMJ Passes Critical Milestone in MMPR Licensing ProcessPRICE SENSITIVE09/04/15
MMJ Trading HaltPRICE SENSITIVE07/04/15
MMJ BBY Research Reports30/03/15
MMJ PYL & MMJ Combine to Create Global Medical Cannabis CompanyPRICE SENSITIVE24/03/15
MMJ Trading HaltPRICE SENSITIVE20/03/15
MMJ Investor Presentation06/03/15
MMJ Agreement to Commercialise Revolutionary Vaporiser DevicePRICE SENSITIVE02/03/15
MMJ Achievement of Performance Rights MilestonesPRICE SENSITIVE23/02/15
MMJ Letter to Shareholders12/02/15
MMJ Clinical Development Path of Buccal and Oral ProductsPRICE SENSITIVE06/02/15
MMJ Final Director's Interest Notice04/02/15
MMJ Initial Director's Interest Notice03/02/15
MMJ Commencement of R&D with YissumPRICE SENSITIVE03/02/15
MMJ Changes to Management02/02/15
MMJ Change of Company Secretary and Registered Office02/02/15
MMJ Appointment of CEO for Israeli Operations29/01/15
MMJ Appointment of Medical Device Expert to Phytotech Board28/01/15
MMJ Yissum Collaboration on Medical Cannabis Delivery System27/01/15
MMJ PHYTOTECH, FIRST MEDICAL CANNABIS COMPANY TO LIST ON THE ASX22/01/15
MMJ Updated statement of financial position20/01/15
MMJ Schedule of Restricted Securities20/01/15
MMJ Letter from Hadassah University Hospital20/01/15
MMJ Letter from Yissum Technology Transfer20/01/15
MMJ Israeli Legal Opinion20/01/15
MMJ Australian Legal Opinion20/01/15
MMJ Amended Terms of Performance Rights20/01/15
MMJ Issue of Performance Rights20/01/15
MMJ Statement of Commitments20/01/15
MMJ Securities Trading Policy20/01/15
MMJ Constitution20/01/15
MMJ Appendix 1A Information Form & Checklist20/01/15
MMJ Top 20 Holders20/01/15
MMJ Distribution Schedule20/01/15
MMJ Pre Quotation Disclosure20/01/15
MMJ Admission to Official ListPRICE SENSITIVE20/01/15
MMJ ASX Notice20/01/15
MMJ Supplementary Prospectus05/01/15
MMJ Prospectus02/12/14
MMJ MMJ Passes Critical Milestone in MMPR Licensing Process
09/04/15PRICE SENSITIVE
MMJ Trading Halt
07/04/15PRICE SENSITIVE
MMJ BBY Research Reports
30/03/15
MMJ PYL & MMJ Combine to Create Global Medical Cannabis Company
24/03/15PRICE SENSITIVE
MMJ Trading Halt
20/03/15PRICE SENSITIVE
MMJ Investor Presentation
06/03/15
MMJ Agreement to Commercialise Revolutionary Vaporiser Device
02/03/15PRICE SENSITIVE
MMJ Achievement of Performance Rights Milestones
23/02/15PRICE SENSITIVE
MMJ Letter to Shareholders
12/02/15
MMJ Clinical Development Path of Buccal and Oral Products
06/02/15PRICE SENSITIVE
MMJ Final Director's Interest Notice
04/02/15
MMJ Initial Director's Interest Notice
03/02/15
MMJ Commencement of R&D with Yissum
03/02/15PRICE SENSITIVE
MMJ Changes to Management
02/02/15
MMJ Change of Company Secretary and Registered Office
02/02/15
MMJ Appointment of CEO for Israeli Operations
29/01/15
MMJ Appointment of Medical Device Expert to Phytotech Board
28/01/15
MMJ Yissum Collaboration on Medical Cannabis Delivery System
27/01/15
MMJ PHYTOTECH, FIRST MEDICAL CANNABIS COMPANY TO LIST ON THE ASX
22/01/15
MMJ Updated statement of financial position
20/01/15
MMJ Schedule of Restricted Securities
20/01/15
MMJ Letter from Hadassah University Hospital
20/01/15
MMJ Letter from Yissum Technology Transfer
20/01/15
MMJ Israeli Legal Opinion
20/01/15
MMJ Australian Legal Opinion
20/01/15
MMJ Amended Terms of Performance Rights
20/01/15
MMJ Issue of Performance Rights
20/01/15
MMJ Statement of Commitments
20/01/15
MMJ Securities Trading Policy
20/01/15
MMJ Constitution
20/01/15
MMJ Appendix 1A Information Form & Checklist
20/01/15
MMJ Top 20 Holders
20/01/15
MMJ Distribution Schedule
20/01/15
MMJ Pre Quotation Disclosure
20/01/15
MMJ Admission to Official List
20/01/15PRICE SENSITIVE
MMJ ASX Notice
20/01/15
MMJ Supplementary Prospectus
05/01/15
MMJ Prospectus
02/12/14
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
ASX Market Close: ASX closes above 8,400pts on green Wednesday | Nov 27, 2024 The ASX finished up around 8,400 points after flirting with the 8,410 level throughout the day, clearly, in a good mood.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.